Cigna Group (CI) stock

CINYSEHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3021% below fair value

$296.27−5.18 (-1.72%)

Close on Nov 12, 2026Market cap $78.29BP/E 13.1Yield 2.04%

Cigna price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cigna's price to sales ratio was 0.3× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.3× to 0.6×, with a median of 0.4×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	0.3×	+0.0
2025	Dec 31, 2025	0.3×	−0.1
2024	Dec 31, 2024	0.3×	−0.1
2023	Dec 29, 2023	0.5×	−0.1
2022	Dec 30, 2022	0.6×	+0.1
2021	Dec 31, 2021	0.5×	−0.0
2020	Dec 31, 2020	0.5×	−0.1
2019	Dec 31, 2019	0.6×	–

Where these numbers come from

Parsed from the XBRL in Cigna's annual and quarterly filings with the SEC
Per-share figures adjusted for the 3-for-1 split on Jun 5, 2007
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CI.

Compare: CI vs ELV · CI vs CNC · CI vs UNH · CI vs HUM · CI vs MOH

Revenue growth6.8% · median 6.5%

Gross margin20.7% · median 50.6%

Operating margin3.4% · median 1.5%

Net margin2.1% · median 0.8%

Company	Revenue	Growth
UNH	$450.13B	+6.5%
CI	$286.32B	+6.8%
CNC	$203.90B	+9.7%
ELV	$201.83B	+3.6%
HUM	$154.19B	+22.0%
MOH	$44.13B	-0.9%

Company

Next earnings (est.): Feb 4, 2027, before open
Exchange: NYSE
Industry: Hospital & Medical Service Plans
Fiscal year ends: December 31
Employees: 67,700
Held by institutions: 89.9%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1739940

Advertisement
300 × 250

See a number that looks wrong?